Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified February 2013 by Universitaire Ziekenhuizen Leuven
Sponsor:
Information provided by (Responsible Party):
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT01788319
First received: February 1, 2013
Last updated: February 7, 2013
Last verified: February 2013

February 1, 2013
February 7, 2013
February 2013
June 2014   (final data collection date for primary outcome measure)
to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm) [ Time Frame: one year of follow-up ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01788319 on ClinicalTrials.gov Archive Site
Secondary the complication rate between the two techniques will be compared [ Time Frame: one year of follow up ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients

This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.

Not Provided
Interventional
Not Provided
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Open Angle Glaucoma
Procedure: lasertrabeculoplasty
Other Name: Conventional (532nm)
Experimental: lasertrabeculoplasty
Intervention: Procedure: lasertrabeculoplasty
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
30
June 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • individuals over 18 years old
  • willing to sign an informed consent and able to comply the requirements of the study
  • having no other ocular diseases besides glaucoma

Exclusion Criteria:

  • history of ocular trauma
  • intraocular surgery (except for phaco)
  • pigment dispersion and exfoliation glaucoma
Both
18 Years to 90 Years
No
Contact: University Hospitals Leuven +32 16 332372
Belgium
 
NCT01788319
S55194
No
Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven
Not Provided
Principal Investigator: Evelien Vandewalle, MD, PhD Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven
February 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP